SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-20-000007
Filing Date
2020-02-13
Accepted
2020-02-13 15:36:21
Documents
43
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 sangui10q20191231vedgar1.htm 10-Q 483989
2 sangui10q20191231audit2021.jpg GRAPHIC 10204
3 sangui10q20191231audit2022.jpg GRAPHIC 19096
4 sangui10q20191231audit2023.jpg GRAPHIC 72159
5 exhibit3101.htm EX-31 7692
6 exhibit3102.htm EX-31 8182
7 exhibit3201.htm EX-32 4303
  Complete submission text file 0001551163-20-000007.txt   1993907

Data Files

Seq Description Document Type Size
8 sgbi-20191231.xml EX-101.INS 267457
9 sgbi-20191231.xsd EX-101.SCH 16240
10 sgbi-20191231_cal.xml EX-101.CAL 25685
11 sgbi-20191231_def.xml EX-101.DEF 53038
12 sgbi-20191231_lab.xml EX-101.LAB 140588
13 sgbi-20191231_pre.xml EX-101.PRE 121761
Mailing Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025
Business Address 352 SOUTH 200 WEST SUITE 3 FARMINGTON UT 84025 011 49 (40) 6093120
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 20610042
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences